摘要:
A computer cluster includes: a first compartment, further including a plurality of first physical nodes configured to provide first resources for a first infrastructural virtual instance and second resources for guest virtual instances; and a second compartment, further including a plurality of second physical nodes configured to provide third resources for a second infrastructural virtual instance and fourth resources for guest virtual instances. Each of the plurality of physical nodes further includes a mass storage device, the mass storage device further including: a partition provided for booting the physical node; a partition as part of resources assigned to an infrastructural virtual instance; and a partition as part of other resources. The first infrastructural virtual instance and the second infrastructural virtual instance are configured for monitoring each other.
摘要:
A computer cluster includes: a first compartment, further including a plurality of first physical nodes configured to provide first resources for guest virtual instances, each of the plurality of first physical nodes further including a mass storage device, the mass storage device further including: a first partition provided for booting the first physical node; and a second partition as part of the first resources; and a second compartment, further including a plurality of second physical nodes configured to provide second resources for guest virtual instances, each of the plurality of second physical nodes further including a mass storage device, the mass storage device including: a third partition provided for booting the second physical node; and a fourth partition as part of the second resources. The first and the second physical nodes are further configured to provide third resources for a plurality of storage management processes.
摘要:
A computer cluster includes: a first compartment, further including a plurality of first physical nodes configured to provide first resources for a first infrastructural virtual instance and second resources for guest virtual instances; and a second compartment, further including a plurality of second physical nodes configured to provide third resources for a second infrastructural virtual instance and fourth resources for guest virtual instances. Each of the plurality of physical nodes further includes a mass storage device, the mass storage device further including: a partition provided for booting the physical node; a partition as part of resources assigned to an infrastructural virtual instance; and a partition as part of other resources. The first infrastructural virtual instance and the second infrastructural virtual instance are configured for monitoring each other.
摘要:
A computer cluster includes: a first compartment, further including a plurality of first physical nodes configured to provide first resources for guest virtual instances, each of the plurality of first physical nodes further including a mass storage device, the mass storage device further including: a first partition provided for booting the first physical node; and a second partition as part of the first resources; and a second compartment, further including a plurality of second physical nodes configured to provide second resources for guest virtual instances, each of the plurality of second physical nodes further including a mass storage device, the mass storage device including: a third partition provided for booting the second physical node; and a fourth partition as part of the second resources. The first and the second physical nodes are further configured to provide third resources for a plurality of storage management processes.
摘要:
The present invention relates to an isolated DNA, which is selected from the following sequences: a) a sequence according to SEQ ID No. 01, b) an intron-free sequence that is derived from a sequence according to a) and encodes the same protein or peptide as the sequence according to SEQ ID No. 01, c) a sequence that encodes a protein or peptide, which comprises the amino acid sequence according to SEQ ID No. 02, d) a sequence that is at least 80% identical to a sequence according to a) to c), e) a sequence that hybridizes with the antisense strand of a sequence according to one of the groups a) to d) or would hybridize taking into account degeneration of the genetic code, f) a derivative of a sequence according to one of the groups a) to e) obtained by substitution, addition, inversion and/or deletion of one or more bases, g) a sequence that corresponds to SEQ ID No. 01 within the degeneration of the genetic code, h) a sequence with neutral sense mutations of SEQ ID No. 01, and i) a sequence complementary to a sequence according to one of the groups a) to h). The invention further relates to a vector, the use of this vector for transformation of a cell, a transformed cell, a polypeptide, cells genetically engineered relative to their wild type, a method of production of a genetically engineered cell, the genetically engineered cell obtainable by this method, the use of this cell and a method of production of 3-hydroxyisobutyric acid or of a derivative thereof.
摘要翻译:本发明涉及分离的DNA,其选自以下序列:a)根据SEQ ID No 01的序列,b)源自根据a)的序列的内含子序列,并编码它们 蛋白质或肽,其为编码蛋白质或肽的序列,其包含根据SEQ ID No.22的氨基酸序列,d)至少80%相同的序列 根据a)至c)的序列,e)与根据a)至d)中的一个组的序列的反义链杂交的序列或将考虑到遗传密码的变性而杂交,f)a 根据通过一个或多个碱基的取代,添加,倒位和/或缺失得到的a)至e)中的一个序列的序列的衍生物,g)在遗传变性中对应于SEQ ID No 01的序列 代码,h)具有SEQ ID No 01的中性有义突变的序列,和i) 与根据a)至h)中的一个组合的序列互补的序列。 本发明进一步涉及载体,该载体用于转化细胞,转化细胞,多肽,相对于其野生型基因工程改造的细胞,遗传工程细胞的生产方法,可获得的遗传工程改造的细胞 通过该方法,可以使用该细胞和3-羟基异丁酸或其衍生物的制造方法。
摘要:
The present invention relates to a cell which has been modified in comparison with its wild type in such a way that it is capable of forming more, by comparison with its wild, 3-hydroxyisobutyric acid or polyhydroxyalkanoates based on 3-hydroxyisobutyric acid via methylmalonate-semialdehyde or 3-hydroxybutyryl-coenzyme A as precursors. The invention also relates to a method of generating a genetically modified cell, to the genetically modified cell obtainable by these methods, to a method of producing 3-hydroxyisobutyric acid or polyhydroxyalkanoates based on 3-hydroxyisobutyric acid, to a method of producing methacrylic acid or methacrylic esters, and to a method of producing polymethacrylic acid or polymethacrylic esters. The present invention furthermore relates to an isolated DNA, to a vector, to the use of this vector for transforming a cell, to a transformed cell, and to a polypeptide.
摘要:
An apparatus for manufacturing an otoplastic. An otoplastic is manufactured directly in the ear of a hearing-impaired person in that a deformable envelope is pulled over a die or over a shell or over an overlayed over-shell. This apparatus is then supplied with flowing otoplastic material between the die and the envelope, being supplied therewith in the ear. The envelope expands and assumes the shape of the auditory canal. After hardening or curing of the otoplastic material in the ear of the hearing-impaired person, the envelope and the die are removed and a module of either an in-the-ear or of a behind-the-ear hearing aid is integrated therewith.
摘要:
The present invention relates to a process for the preparation of methacrylic acid or methacrylic esters, comprising the process steps of IA) preparation of 3-hydroxyisobutyric acid by a process comprising the process step of bringing a cell which has been genetically modified in comparison with its wild type in such a way that it is capable of forming more 3-hydroxyisobutyric acid, or polyhydroxyalkanoates based on 3-hydroxyisobutyric acid in comparison with its wild type, into contact with a nutrient medium comprising, as carbon source, carbohydrates, glycerol, carbon dioxide, methanol, L-valine or L-glutamate under conditions under which 3-hydroxyisobutyric acid or polyhydroxyalkanoates based on 3-hydroxyisobutyric acid are formed from the carbon source, if appropriate, isolation of the 3-hydroxyisobutyric acid from the nutrient medium and also, if appropriate, neutralization of the 3-hydroxyisobutyric acid, IB) dehydration of the 3-hydroxyisobutyric acid with formation of methacrylic acid and also, where appropriate, esterification methacrylic acid. The invention also relates to a process for the preparation of polymethacrylic acid or polymethacrylic esters.
摘要:
The present invention relates to a process for the preparation of methacrylic acid or methacrylic esters, comprising the process steps of IA) preparation of 3-hydroxyisobutyric acid by a process comprising the process step of bringing a cell which has been genetically modified in comparison with its wild type in such a way that it is capable of forming more 3-hydroxyisobutyric acid, or polyhydroxyalkanoates based on 3-hydroxyisobutyric acid in comparison with its wild type, into contact with a nutrient medium comprising, as carbon source, carbohydrates, glycerol, carbon dioxide, methanol, L-valine or L-glutamate under conditions under which 3-hydroxyisobutyric acid or polyhydroxyalkanoates based on 3-hydroxyisobutyric acid are formed from the carbon source, if appropriate, isolation of the 3-hydroxyisobutyric acid from the nutrient medium and also, if appropriate, neutralization of the 3-hydroxyisobutyric acid, IB) dehydration of the 3-hydroxyisobutyric acid with formation of methacrylic acid and also, where appropriate, esterification methacrylic acid. The invention also relates to a process for the preparation of polymethacrylic acid or polymethacrylic esters.
摘要:
The present invention relates to a cell which has been modified in comparison with its wild type in such a way that it is capable of forming more, by comparison with its wild, 3-hydroxyisobutyric acid or poly-hydroxyalkanoates based on 3-hydroxyisobutyric acid via methylmalonate-semialdehyde or 3-hydroxybutyryl-coenzyme A as precursors. The invention also relates to a method of generating a genetically modified cell, to the genetically modified cell obtainable by these methods, to a method of producing 3-hydroxyisobutyric acid or polyhydroxyalkanoates based on 3-hydroxyisobutyric acid, to a method of producing methacrylic acid or methacrylic esters, and to a method of producing polymethacrylic acid or polymethacrylic esters. The present invention furthermore relates to an isolated DNA, to a vector, to the use of this vector for transforming a cell, to a transformed cell, and to a polypeptide.